Scientific publications on lymphomas

Home > Scientific publications on lymphomas

The results and conclusions of the work conducted by the Lymphoma Research Experts ecosystem are published in leading medical journals.

Lysa 2022_LYSA_The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
Baptiste Eluard, Stéphanie Nuan-Aliman, Nathalie Faumont, Davi Collares, Didier Bordereaux, Aurélie Montagne, Isabelle Martins, Nicolas Cagnard, Martial Caly, Oussama Taoui, Leonardo Lordello, Jacqueline Lehmann-Che, Bruno Tesson, Jose-Angel Angel Martinez-Climent, Christiane Copie-Bergman, Corinne Haioun, Herve Tilly, Benjamin Bonsang, Anne Vincent-Salomon, Jean-Philippe Jais, Fabrice Jardin, Karen Leroy, Maria Chiara Maiuri, Guido Kroemer, Thierry Jo Molina, Jean Feuillard, Véronique Baud
Blood . 2022 Jan 20;139(3):384-398. Learn more
Lysa 2022_LYSA_Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
Aspasia Stamatoullas, Hervé Ghesquières, Pierre Feugier, Marc André, Fabien Le Bras, Anne-Claire Gac, Cécile Borel, Thomas Gastinne, Philippe Quittet, Franck Morschhauser, Vincent Ribrag, Stephanie Guidez, Emmanuelle Nicolas-Virelizier, Alina Berriolo-Riedinger, Thierry Vander Borght, Véronique Edeline, Pauline Brice
doi: 10.1080/10428194.2022.2107204. Learn more
Lysa 2022_LYSA_Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
Franck Morschhauser, Loretta Nastoupil, Pierre Feugier, Jean-Marc Schiano de Colella, Hervé Tilly, Maria Lia Palomba, Emmanuel Bachy, Christophe Fruchart, Edward N Libby, Rene-Olivier Casasnovas, Ian W Flinn, Corinne Haioun, Hervé Maisonneuve, Loic Ysebaert, Nancy L Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Steven Le Gouill, Nicolas Daguindau, Stéphanie Guidez, Gian Matteo Pica, Alejandro Martín García-Sancho, Armondo López-Guillermo, Jean-François Larouche, Kiyoshi Ando, Maria Gomes da Silva, Marc André, Wu Kalung, Laurie H Sehn, Koji Izutsu, Guillaume Cartron, Argyrios Gkasiamis, Russell Crowe, Luc Xerri, Nathan H Fowler, Gilles Salles
J Clin Oncol . 2022 Aug 10;JCO2200843. Learn more
Lysa 2022_LYSA_Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial
Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, Rene-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Krimo Bouabdallah, Pierre Feugier, Lena Specht, Lysiane Molina, Mohamed Touati, Cecile Borel, Aspasia Stamatoullas, Emmanuelle Nicolas-Virelizier, Laurent Pascal, Pieternella Lugtenburg, Nicola Di Renzo, Thierry Vander Borght, Alexandra Traverse-Glehen, Peggy Dartigues, Martin Hutchings, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, for the LYSA-FIL-EORTC Intergroup
doi: 10.1200/JCO.21.01281. Learn more
Lysa 2022_LYSA_High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline
Rossi C, André M, Dupuis J, Morschhauser F, Joly B, Lazarovici J, Ghesquières H, Stamatoullas A, Nicolas-Virelizier E, Feugier P, Gac AC, Moatti H, Fornecker LM, Deau B, Joubert C, Fortpied C, Raemaekers J, Federico M, Kanoun S, Meignan M, Traverse-Glehen A, Cottereau AS, Casasnova RO
doi: 10.3324/haematol.2021.280004 Learn more
Lysa 2022_LYSA_Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial
Vincent Camus, Aurelien Belot, Lucie Obéric, David Sibon, Herve Ghesquieres, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean-Marie Michot, Thierry Molina, Andre Bosly, Clementine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Herve Tilly
10.1182/bloodadvances.2022007609. Learn more
Lysa 2022_LYSA_Oncogenetic landscape of lymphomagenesis in coeliac disease
Sascha Cording, Ludovic Lhermitte, Georgia Malamut, Sofia Berrabah, Amélie Trinquand, Nicolas Guegan, Patrick Villarese, Sophie Kaltenbach, Bertrand Meresse, Sherine Khater, Michael Dussiot, Marc Bras, Morgane Cheminant, Bruno Tesson, Christine Bole-Feysot, Julie Bruneau, Thierry Jo Molina, David Sibon, Elizabeth Macintyre, Olivier Hermine, Christophe Cellier, Vahid Asnafi, Nadine Cerf-Bensussan, CELAC network
Gut . 2022 Mar;71(3):497-508. Learn more
Lysa 2022_LYSA_PET-driven strategy in advanced Hodgkin lymphoma: prolonged follow-up of the AHL2011 Phase III LYSA study
René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquieres, Aspasia Stamatoullas, Jehan Dupuis, Anne-Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Franck Morschhauser, David Sibon, Christophe Bonnet, Alina Berriolo-Riedinger, Véronique Edeline, Marie Parrens, Diane Damotte, Diane Coso, Marc André, Michel Meignan, Cédric Rossi
J Clin Oncol . 2022 Apr 1;40(10):1091-1101. Learn more
Lysa 2022_LYSA_Lenalidomide-induced arthritis: A case report and review of literature and pharmacovigilance databases
Charlotte Icard, Pauline Mocquot, Jean-Claude Nogaro, Fabien Despas, Martin Gauthier
J Oncol Pharm Pract . 2022 Mar;28(2):453-456. Learn more
Lysa 2022_LYSA_Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials
Carla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard Hochster, Wolfgang Hiddemann, Robert E Marcus, Eva K Kimby, Michael Herold, Catherine J Sebban, Emmanuel Gyan, Kenneth A Foon, Tina G Nielsen, Umberto Vitolo, Gilles Andre Salles, Qian Shi, Christopher R Flowers
Blood . 2022 Mar 17;139(11):1684-1693. Learn more
Lysa 2022_LYSA_A guide to ComBat harmonization of imaging biomarkers in multicenter studies
Fanny Orlhac, Jakoba J. Eertink, Anne-Ségolène Cottereau, Josée M. Zijlstra, Catherine Thieblemont, Michel Meignan, Ronald Boellaard, Irène Buvat
J Nucl Med . 2022 Feb;63(2):172-179. Learn more
Lysa 2022_LYSA_Deep Learning approach to automatize TMTV calculation regardless of segmentation methodology for main FDG avid lymphomas
Wendy Revailler, Anne-Ségolène Cottereau, Cédric Rossi, Rudy Noyelle, Thomas Trouillard, Franck Morschhauser, Rene-Olivier Casasnovas, Catherine Thieblemont, Steven Le Gouill, Marc P-E André, Hervé Ghesquières, Romain Ricci, Michel Meignan, Salim Kanoun
Diagnostics (Basel) . 2022 Feb 6;12(2):417. Learn more
Lysa 2022_LYSA_Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
Roch Houot, Viola Poeschel, Bettina Altmann, Stephanie Angel, Lorenz Thurner, Thomas Illmer, Marc Andre, Martin Dreyling, Hervé Maisonneuve, Hervé Tilly, Stephanie Mayer, Olivier Casasnovas, Steven Le Gouill, Fritz Offner, Guillaume Cartron, Andrea Kerkhoff, Thomas Weber, Joerg Hoffmann, Marita Ziepert, Wolfram Klapper, Emmanuel Itti, Dirk Hellwig, Giorgi Natchkebia, Laurence de Leval, Andreas Rosenwald, Corinne Haioun, Laurent Dercle, Philippe Gaulard, Gerhard Held
Hemasphere . 2022 Jan 10;6(2):e672. Learn more
Lysa 2022_LYSA_Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
Alexandra‑Cristina Paunescu, Christiane Copie Bergman, Sandra Malak, Steven Le Gouill, Vincent Ribrag, Krimo Bouabdallah, David Sibon, Gerhard Rumpold, Marie Preau, Nicolas Mounier, Corinne Haioun, Fabrice Jardin, Caroline Besson
Ann Hematol . 2022 Feb;101(2):317-332. Learn more
Lysa 2022_LYSA_Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
Christophe Bonnet, Jehan Dupuis, Hervé Tilly, Thierry Lamy, Christophe Fruchart, Steven le Gouill, Catherine Thieblemont, Franck Morschhauser, Olivier Casasnovas, Krimo Bouabdallah, Hervé Ghesquieres, Eric Van Den Neste, Marc André, Guillaume Cartron, Gilles Salles
Cancers (Basel) 2022 Mar 30;14(7):1761. doi: 10.3390/cancers14071761. Learn more
Lysa 2022_LYSA_Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study
Virginie Nerich, Christophe Guyeux, Michel Henry-Amar, Raphaël Couturier, Catherine Thieblemont, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René-Olivier Casasnovas, Franck Morschhauser, Pierre Feugier, David Sibon, Loic Ysebaert, Emmanuelle Nicolas-Virelizier, Florence Broussais-Guillaumot, Gandhi L Damaj, Jean-Philippe Jais, Gilles Salles, Macha Woronoff-Lemsi, Nicolas Mounier
Cancer . 2022 Feb 1;128(3):519-528. doi: 10.1002/cncr.33938. Learn more
Lysa 2022_LYSA_Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
Emmanuel Bachy; Vincent Camus; Catherine Thieblemont; David Sibon; René-Olivier Casasnovas; Loïc Ysebaert; Gandhi Damaj; Stéphanie Guidez; Gian Matteo Pica; Won Seog Kim; Soon Thye Lim; Marc André; Alejandro Martín García-Sancho; Maria Jesus Penarrubia; Philipp B. Staber; Judith Trotman; Andreas Hüttmann; Vittorio Stefoni; Alessandro Re; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Michel Meignan; Ju Li; Franck Morschhauser; and Richard Delarue
J Clin Oncol . 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. Learn more
Lysa 2022_LYSA_Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Hervé Tilly, Franck Morschhauser, Laurie H Sehn, Jonathan W Friedberg, Marek Trněný, Jeff P Sharman, Charles Herbaux, John M Burke, Matthew Matasar, Shinya Rai, Koji Izutsu, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan M Bergua-Burgués, Matthew C Cheung, Antonio Pinto, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh-Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R Flowers, Gilles Salles
N Engl J Med . 2022 Jan 27;386(4):351-363. doi: 10.1056/NEJMoa2115304. Learn more
Lysa 2022_LYSA_Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos, Pauline Brice, David Sibon, Jean Marc Schiano, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Baptiste Delapierre, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Caroline Besson, Eric Durot, Christophe Bonnet, Ludovic Fouillet, Fontanet Bijou, Oliver Tournilhac, Philippe Gaulard, Marie-Cécile Parrens, Gandhi Damaj on behalf of the LYSA group
DOI: 10.1182/bloodadvances.2022008524 Learn more
Lysa 2022_LYSA_Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials
Valeria Fiaccadori, Anouk Neven, Catherine Fortpied, Igor Aurer, Marc Andre, Massimo Federico, Nicholas Counsell, Elizabeth H Phillips, Laura Clifton-Hadley, Sally F Barrington, Timothy Illidge, John Radford, John M M Raemaekers
DOI: 10.1111/bjh.18594 Learn more
Lysa 2022_LYSA_ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study
David Sibon, Bettina Bisig, Christophe Bonnet, Elsa Poullot, Emmanuel Bachy, Doriane Cavalieri, Virginie Fataccioli, Cloe Bregnard, Fanny Drieux, Julie Bruneau, Francois Lemonnier, Aurelie Dupuy, Celine Bossard, Marie Parrens, Krimo Bouabdallah, Nicolas Ketterer, Gregoire Berthod, Anne Cairoli, Gandhi Damaj, Olivier Tournilhac, Jean-Philippe Jais, Philippe Gaulard, Laurence De Leval
DOI: 10.3324/haematol.2022.281442 Learn more
Lysa 2022_LYSA_Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study
Georg Hess, Martin Dreyling, Lucie Oberic, Eva Gine, Pier Luigi Zinzani, Kim Linton, Adam Vilmar, Mats Jerkeman, Jenny M H Chen, Anke Ohler, Stephan Stilgenbauer, Catherine Thieblemont, Jonathan Lambert, Vittorio Ruggero Zilioli, Juan-Manuel Sancho, Ana Jiménez-Ubieto, Luca Fischer, Toby A Eyre, Sam Keeping, Julie E Park, James J Wu, Rubina Siddiqi, John Reitan, Sally Wade, Gilles Salles
DOI: 10.1111/bjh.18519 Learn more
Lysa 2022_LYSA_Molecular Monitoring of Lymphomas
Joseph G. Schroers-Martin, Stefan Alig, Andrea Garofalo, Benoit Tessoulin, Takeshi Sugio, Ash A. Alizadeh
DOI: 10.1146/annurev-pathol-050520-044652 Learn more
Lysa 2022_LYSA_European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri , Julia Furtner, Jaime Gallego Perez-Larraya, Roger Henriksson, Andreas F Hottinger, Benjamin Kasenda, Florence Lefranc, Alexander Lossos, Catherine McBain, Matthias Preusser, Patrick Roth, Roberta Rudà, Uwe Schlegel, Riccardo Soffietti, Carole Soussain, Martin J B Taphoorn, Valérie Touitou, Michael Weller, Jacoline E C Bromberg
DOI: 10.1093/neuonc/noac196 Learn more